Chargement en cours...
Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B lymphocyte stimulator (BLyS, also known as B cell-activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration (FDA) and the European Medicines Evaluation Agency for the...
Enregistré dans:
| Publié dans: | Drug Des Devel Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7323799/ https://ncbi.nlm.nih.gov/pubmed/32612353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S216193 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|